Technical Analysis for SRNE - Sorrento Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 3.35 0.60% 0.02
SRNE closed up 0.6 percent on Tuesday, November 20, 2018, on 51 percent of normal volume.

Earnings due: Nov 22

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical SRNE trend table...

Date Alert Name Type % Chg
Nov 20 Wide Bands Range Expansion 0.00%
Nov 19 Fell Below 20 DMA Bearish 0.60%
Nov 19 180 Bearish Setup Bearish Swing Setup 0.60%
Nov 19 Wide Bands Range Expansion 0.60%
Nov 16 20 DMA Support Bullish -9.70%
Nov 16 Wide Bands Range Expansion -9.70%
Nov 15 Bullish Engulfing Bullish -6.94%
Nov 15 Crossed Above 20 DMA Bullish -6.94%
Nov 15 Wide Bands Range Expansion -6.94%
Nov 14 Fell Below 20 DMA Bearish 1.82%

Older signals for SRNE ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Sorrento Therapeutics, Inc., a development stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel and proprietary biotherapeutics for the treatment of cancer, inflammation, metabolic, and infectious diseases in the United States. The company's G-MAB, a human antibody library platform, facilitates the rapid identification and isolation of highly specific antibody therapeutic product candidates that bind to disease targets appropriate for antibody therapy. Its human antibody library technology is used to construct large human antibody libraries. It has license agreement with OPKO Health, Inc. to develop, manufacture, use, market, sell, offer to sell, import, and export certain products related to the development, manufacture, marketing, and sale of drugs for ophthalmological indications. Sorrento Therapeutics, Inc. is based in San Diego, California.
Is SRNE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.65
52 Week Low 2.15
Average Volume 1,766,112
200-Day Moving Average 5.9632
50-Day Moving Average 3.8155
20-Day Moving Average 3.4605
10-Day Moving Average 3.624
Average True Range 0.3676
ADX 20.51
+DI 18.9183
-DI 25.3138
Chandelier Exit (Long, 3 ATRs ) 3.4572
Chandelier Exit (Short, 3 ATRs ) 4.0528
Upper Bollinger Band 4.0657
Lower Bollinger Band 2.8553
Percent B (%b) 0.41
BandWidth 34.977604
MACD Line -0.0872
MACD Signal Line -0.1024
MACD Histogram 0.0152
Fundamentals Value
Market Cap 231.05 Million
Num Shares 69 Million
EPS -0.66
Price-to-Earnings (P/E) Ratio -5.09
Price-to-Sales 10.91
Price-to-Book 1.87
PEG Ratio -0.06
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.68
Resistance 3 (R3) 3.66 3.52 3.63
Resistance 2 (R2) 3.52 3.44 3.54 3.61
Resistance 1 (R1) 3.44 3.39 3.48 3.46 3.59
Pivot Point 3.30 3.30 3.33 3.32 3.30
Support 1 (S1) 3.22 3.22 3.26 3.24 3.11
Support 2 (S2) 3.08 3.17 3.10 3.09
Support 3 (S3) 3.00 3.08 3.08
Support 4 (S4) 3.02